Literature DB >> 10147029

A review of limited lists and formularies: are they cost-effective?

M J Pearce1, E J Begg.   

Abstract

The 'limited list' or 'formulary' concept has been used to promote rational use of drugs and to set standards for drug use. Recently the concept has been aimed more toward containment of drug costs. Effective hospital formulary systems assist in purchasing and inventory management. Application of the formulary concept has resulted in savings within specific classes of drugs and in total hospital drug costs. Key features which promote effectiveness are development of policies by prescriber consensus and continued education along with feedback on drug usage. The formulary concept also provides a foundation for appropriate use of drugs in hospitals. In the community setting, limited lists can achieve cost savings and can assist in the rational use of drugs. National limited lists have been less successful in controlling overall drug costs, probably because they have focused on economic effects, rather than education, feedback or user participation. Properly organised drug rationalisation policies embracing the limited list concept can improve health outcomes by promoting rational drug use. They can also contain or reduce drug costs.

Mesh:

Year:  1992        PMID: 10147029     DOI: 10.2165/00019053-199201030-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  70 in total

1.  The community pharmacist as a resource for the family physician.

Authors:  A M Hawkins; J W Orchard; S E Evers
Journal:  Can Fam Physician       Date:  1985-10       Impact factor: 3.275

2.  Prescribing costs when computers are used to issue all prescriptions.

Authors:  J B Donald
Journal:  BMJ       Date:  1989-07-01

3.  Quality control of hospital formularies.

Authors:  T D Rucker
Journal:  Pharm Weekbl Sci       Date:  1988-08-19

4.  ASHP statement on the formulary system.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1986-11

5.  Reducing cephalosporin purchases.

Authors:  J Mioduch; T G Burnakis
Journal:  Drug Intell Clin Pharm       Date:  1985-03

6.  GAO report on hospital purchasing and inventory management. U.S. General Accounting Office.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1979-09

7.  Effect of aminoglycoside-use restrictions on drug cost.

Authors:  O H DeTorres; R E White
Journal:  Am J Hosp Pharm       Date:  1984-06

8.  Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs.

Authors:  P W Abramowitz; E G Nold; S M Hatfield
Journal:  Am J Hosp Pharm       Date:  1982-07

9.  Effect of formulary restriction of cefotaxime usage.

Authors:  J M DeVito; J F John
Journal:  Arch Intern Med       Date:  1985-06

10.  Cost containment through restriction of cephalosporins.

Authors:  H L Britton; T L Schwinghammer; M J Romano
Journal:  Am J Hosp Pharm       Date:  1981-12
View more
  16 in total

1.  Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies?

Authors:  M Duerden; T Walley
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

Review 2.  Economic impact of cost-containment strategies in third party programmes in the US. Part II.

Authors:  C M Kozma; R M Schulz; W M Dickson; J T Dye; E R Cox; D A Holdford; L Michael; W N Yates; T L Young
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

3.  Economic constraints and prescribing patterns in New Zealand.

Authors:  G S Kellaway
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

4.  The formulary decision-making process in a US academic medical centre.

Authors:  D B Nash; M L Catalano; C J Wordell
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

5.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

6.  Determinants of hospital drug expenditures in Western Europe.

Authors:  P Thürmann; S Harder
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

Review 7.  Drug utilisation review and pharmacoeconomics: interaction after parallel development?

Authors:  S Garattini; G Tognoni
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

8.  Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.

Authors:  R J Lipsy
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

9.  A UK national prescribing list?

Authors:  T Walley
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

10.  Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study.

Authors:  Allan Buusman; Morten Andersen; Camilla Merrild; Beth Elverdam
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.